GeneThera (OTC: GTHR)
Some price data may be temporarily unavailable.
GeneThera Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
GeneThera Company Info
GeneThera, Inc. is a biotechnology company that focuses on eradicating zoonotic diseases such as COVID-19 (Novel Coronavirus), Paratuberculosis (Johne’s disease), Mad Cow Disease, Chronic Wasting Disease, and E.coli and Salmonella infections by applying proprietary molecular sciences and technologies. The firm is working on novel molecular diagnostic tests, therapeutics, and vaccine solutions through robotic technologies to meet the demands of the veterinary, agriculture, and healthcare industries. The company was founded by Antonio Milici in November 1998 and is headquartered in Westminster, CO.
News & Analysis
No articles found.
Valuation
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.